172
Participants
Start Date
November 30, 2016
Primary Completion Date
June 30, 2017
Study Completion Date
June 30, 2017
WO2085 Moisturising Cream
2.5 g of the investigational product WO2085 Moisturising Cream will be applied intravaginally, once daily in the evening. After improvement of the symptoms the frequency may be reduced by the patient as needed. In addition 0.5 g (1 fingertip unit) may be applied to the outer genital area as needed (also several times per day).
Estriol Cream 0.1%
0.5 g of the reference product Estriol Cream 0.1% will be applied intravaginally once daily in the evening for the first 3 weeks. Subsequently, the frequency will be reduced to twice a week for the last 3 weeks for all patients in this treatment group.
Dr. Gerick, Aachen
Praxis für die Frau, Mölln
proDERM Institute for Applied Dermatological Research, Schenefeld
Praxis für die Frau, Schwarzenbek
Frauenklinik Inselspital Bern, Bern
proDERM Institut für Angewandte Dermatologische Forschung GmbH
UNKNOWN
Bremer Pharmacovigilance Service GmbH
OTHER
GCP-Service International Ltd. & Co. KG
INDUSTRY
Dr. August Wolff GmbH & Co. KG Arzneimittel
INDUSTRY